Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000232 · ClinicalTrials.gov registry record
Impact of Unapproved Drug Initiative on Colchicine Use
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 185
- Enrollment target
NCT02000232: Completed study, sponsored by Stanford University.
NCT02000232 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 185 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02000232 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
Study Summary
Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings. Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.
Primary Outcome
We expect to understand the impact of regulatory approach to colchicine preparation and how marketing can affect clinical use patterns in the real world.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-09 |
What the finished NCT02000232 record still lists
NCT02000232 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02000232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02000232 about?
NCT02000232 is a clinical study titled "Impact of Unapproved Drug Initiative on Colchicine Use". Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings. Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.
What is the current status of trial NCT02000232?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2013-01. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT02000232?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia